Premium
P1‐001: CSF CHOLINE ACETYLTRANSFERASE SHOWS DIFFERENTIAL LEVELS AMONG HEALTHY CONTROLS AND PATIENTS WITH AD AND MCI
Author(s) -
Karami Azadeh,
Darreh-Shori Taher,
Zetterberg Henrik,
Blennow Kaj,
Eriksdotter Maria
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.002
Subject(s) - choline acetyltransferase , cerebrospinal fluid , medicine , neurology , dementia , extracellular , cholinergic , acetylcholine , cognition , endocrinology , cognitive impairment , frontotemporal dementia , psychology , disease , chemistry , psychiatry , biochemistry
P1-001 CSF CHOLINE ACETYLTRANSFERASE SHOWS DIFFERENTIAL LEVELS AMONG HEALTHY CONTROLS AND PATIENTS WITH AD AND MCI Azadeh Karami, Taher Darreh-Shori, Henrik Zetterberg, Kaj Blennow, Maria Eriksdotter, Center for Alzheimer Research, Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M€olndal, Sweden; UK Dementia Research Institute at UCL, London, United Kingdom; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, M€olndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, United Kingdom; Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden, Gothenburg, Sweden; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, M€olndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Molndal, Sweden; Theme Aging, Karolinska University Hospital, Stockholm, Sweden. Contact e-mail: azadeh.karami@ki.se